PMID- 21125730 OWN - NLM STAT- MEDLINE DCOM- 20110217 LR - 20181201 IS - 1660-9379 (Print) IS - 1660-9379 (Linking) VI - 6 IP - 267 DP - 2010 Oct 20 TI - [Should we believe in the interaction between proton pump inhibitors (PPI) and clopidogrel]. PG - 1970, 1972-5 AB - Recently, some authors have examined the possibility of an interaction between proton pump inhibitors (especially omeprazole) and clopidogrel. Pharmacodynamically, this interaction is proven and leads to a reduction in anti-aggregation activity. Nevertheless, the clinical implications are not fully clarified. We are all waiting for a randomised prospective study assessing specifically this issue. Meanwhile, caution is recommended when prescribing PPI in patients taking clopidogrel. FAU - Besse, Valentina AU - Besse V AD - Service de medecine interne generale, Departement de medecine interne, HUG, 1211 Geneve 14. Valentina.Pelloni@hcuge.ch FAU - Gerstel, Eric AU - Gerstel E LA - fre PT - Journal Article TT - Faut-il croire a l'interaction entre les inhibiteurs de la pompe a protons et le clopidogrel? PL - Switzerland TA - Rev Med Suisse JT - Revue medicale suisse JID - 101219148 RN - 0 (Platelet Aggregation Inhibitors) RN - 0 (Proton Pump Inhibitors) RN - A74586SNO7 (Clopidogrel) RN - EC 1.14.14.1 (Aryl Hydrocarbon Hydroxylases) RN - EC 1.14.14.1 (CYP2C19 protein, human) RN - EC 1.14.14.1 (Cytochrome P-450 CYP2C19) RN - OM90ZUW7M1 (Ticlopidine) SB - IM MH - Aryl Hydrocarbon Hydroxylases/genetics MH - Clopidogrel MH - Cytochrome P-450 CYP2C19 MH - Drug Interactions MH - Humans MH - Platelet Aggregation Inhibitors/*adverse effects MH - Polymorphism, Genetic MH - Proton Pump Inhibitors/*adverse effects MH - Ticlopidine/adverse effects/*analogs & derivatives EDAT- 2010/12/04 06:00 MHDA- 2011/02/18 06:00 CRDT- 2010/12/04 06:00 PHST- 2010/12/04 06:00 [entrez] PHST- 2010/12/04 06:00 [pubmed] PHST- 2011/02/18 06:00 [medline] PST - ppublish SO - Rev Med Suisse. 2010 Oct 20;6(267):1970, 1972-5.